AiArthritis logo showing stylized infinite loop symbol in red with black dots, above organization name for International Foundation for Autoimmune & Autoinflammatory Arthritis.

Education & Awareness

Our Role in Education and Awareness


We rely on the voices of those affected by these diseases to guide our education and awareness initiatives to prevent misunderstandings, accelerate diagnosis, improve disease management, and advance global awareness. 


Experienced Advocates. Several people leading our organization has served on advisory panels, participated in focus groups, and presented at conferences - all to help the public and other stakeholders understand the awareness and education needs of our community.


Peer-to-Peer Communications. We do not represent the patient voice, we are the patient voice. Whether we are hosting discussions to explore issues of unmet need or to help our community understand complex topics, we are trusted peers and appreciated leaders.


Cross Category Initiatives.  While we focus on improving education, advocacy, and research, our work often overlaps these pillars, as one often influences the other.

Featured Initiatives


Our work is based on conversations, problem-solving, and action. Our voices drive what we do - not only as a story to enhance our work, but also as the reason why we choose our initiatives and how we accomplish our goals.


* In 2017, the International Still's Disease Foundation (ISDF) dissolved into AiArthritis. As a result, we honored a commitment to continue their work to provide resources and educational materials that can help expedite diagnosis and maintain quality of life to those impacted by Still's Disease. We plan to develop similar patient-led educational materials for other disease groups we cover over the next several years.

Education & Awareness Priorities for 2025

Educational Resources

Based on our new "patient journey" designed website, and in conjunction with our blog and existing programs, we will publish 100's of resources to help patients from pre-diagnosis through comorbidities and remission.

Awareness to Expedite Diagnosis

Through a variety of programs we aim to help the public and "first line" health practitioners identify our diseases and expedite diagnosis and therapeutic intervention. Focus on diverse demographics, "mystery patients", the undiagnosed, and those most at risk.

Biosimilars Education

Although biosimilars have been proven to be as safe and effective as the brand drug ("originator"), complex patients and some physicians worry about non-active ingredients or changing methods of administration (shot, injection, pill). AiArthritis hopes we can help patients make the transition and talk to their doctor if they have any concerns.

Shared-Decision Making and Patient-Physician Communication Aids

Help patients by designing peer-led guidance and tools so they feel empowered to participate in discussions with healthcare professionals. These tools can help to improve disease management.

World AUTOimmune & AUTOinflammatory Arthritis Day

As the hosts of World AUTOimmune & AUTOinflammatory Arthritis Day every May 20th, we strive to DRIVE global awareness of all AiArthritis diseases and the issues we face individually and as a community.

Share by: